Programming of Host Metabolism by the Gut Microbiota

Bäckhed, Fredrik
August 2011
Annals of Nutrition & Metabolism;Aug2011 Supplement, Vol. 58, p44
Academic Journal
The human gut harbors a vast ensemble of bacteria that has co-evolved with the human host and performs several important functions that affect our physiology and metabolism. The human gut is sterile at birth and is subsequently colonized with bacteria from the mother and the environment. The complexity of the gut microbiota is increased during childhood, and adult humans contain 150-fold more bacterial genes than human genes. Recent advances in next-generation sequencing technology and mechanistic testing in gnotobiotic mice have identified the gut microbiota as an environmental factor that contributes to obesity. Germ-free mice are protected against developing diet-induced obesity and the underlying mechanisms whereby the gut microbiota contributes to host metabolism are beginning to be clarified. The obese phenotype is associated with increased microbial fermentation and energy extraction; however, other microbially modulated mechanisms contribute to disease progression as well. The gut microbiota has profound effects on host gene expression in the enterohepatic system, including genes involved in immunity and metabolism. For example, the gut microbiota affects expression of secreted proteins in the gut, which modulate lipid metabolism in peripheral organs. In addition, the gut microbiota is also a source of proinflammatory molecules that augment adipose inflammation and macrophage recruitment by signaling through the innate immune system. TLRs (Toll-like receptors) are integral parts of the innate immune system and are expressed by both macrophages and epithelial cells. Activation of TLRs in macrophages dramatically impairs glucose homeostasis, whereas TLRs in the gut may alter the gut microbial composition that may have profound effects on host metabolism. Accordingly, reprogramming the gut microbiota, or its function, in early life may have beneficial effects on host metabolism later in life. Copyright © 2011 S. Karger AG, Basel


Related Articles

  • Gut Microbiota and Host Metabolism: What Relationship. Mithieux, Gilles // Neuroendocrinology;May2018, Vol. 106 Issue 4, p352 

    A large number of genomic studies have reported associations between the gut microbiota composition and metabolic diseases such as obesity or type 2 diabetes. This led to the widespread idea that a causal relationship could exist between intestinal microbiota and metabolic diseases. At odds with...

  • The hybrid science of diet, microbes, and metabolic health. Shanahan, Fergus; Murphy, Eileen // American Journal of Clinical Nutrition;Jul2011, Vol. 94 Issue 1, p1 

    The author discusses the interactions of diet, microbes, and fat metabolism as well as the risk of metabolic disease. The author cites evidence linking the effect of disturbances of innate immunity on microbiota which adversely influence inflammatory response and risk of obesity and diabetes....

  • Gut Microbiota Signatures Predict Host and Microbiota Responses to Dietary Interventions in Obese Individuals. Korpela, Katri; Flint, Harry J.; Johnstone, Alexandra M.; Lappi, Jenni; Poutanen, Kaisa; Dewulf, Evelyne; Delzenne, Nathalie; de Vos, Willem M.; Salonen, Anne // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Background: Interactions between the diet and intestinal microbiota play a role in health and disease, including obesity and related metabolic complications. There is great interest to use dietary means to manipulate the microbiota to promote health. Currently, the impact of dietary change on...

  • Gut microbiome and its role in obesity and insulin resistance. Lee, Clare J.; Sears, Cynthia L.; Maruthur, Nisa // Annals of the New York Academy of Sciences;Feb2020, Vol. 1461 Issue 1, p37 

    Obesity is a complex metabolic disease caused, in part, by the interaction between an individual's genetics, metabolism, and environment. Emerging evidence supports the role of gut microbiota in mediating the interaction between the host and environment by extracting energy from food otherwise...

  • Non Digestible Oligosaccharides Modulate the Gut Microbiota to Control the Development of Leukemia and Associated Cachexia in Mice. Bindels, Laure B.; Neyrinck, Audrey M.; Salazar, Nuria; Taminiau, Bernard; Druart, Céline; Muccioli, Giulio G.; François, Emmanuelle; Blecker, Christophe; Richel, Aurore; Daube, Georges; Mahillon, Jacques; de los Reyes-Gavilán, Clara G.; Cani, Patrice D.; Delzenne, Nathalie M. // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    We tested the hypothesis that changing the gut microbiota using pectic oligosaccharides (POS) or inulin (INU) differently modulates the progression of leukemia and related metabolic disorders. Mice were transplanted with Bcr-Abl-transfected proB lymphocytes mimicking leukemia and received either...

  • Gut: Why do the different people's bodies react differently to a high-fat diet?  // Biomedical Market Newsletter;4/28/2012, Vol. 21, p1 

    The article focuses on a study, according to which the composition of the gut flora determine the way in which the body develops metabolic disorders such as diabetes, regardless of any genetic modification, gender, age or specific diet.

  • Characterisation of Gut Microbiota in Ossabaw and Göttingen Minipigs as Models of Obesity and Metabolic Syndrome. Pedersen, Rebecca; Ingerslev, Hans-Christian; Sturek, Michael; Alloosh, Mouhamad; Cirera, Susanna; Christoffersen, Berit Ø.; Moesgaard, Sophia G.; Larsen, Niels; Boye, Mette // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Background: Recent evidence suggests that the gut microbiota is an important contributing factor to obesity and obesity related metabolic disorders, known as the metabolic syndrome. The aim of this study was to characterise the intestinal microbiota in two pig models of obesity namely...

  • Gut permeability, obesity, and metabolic disorders: who is the chicken and who is the egg? Fasano, Alessio // American Journal of Clinical Nutrition;1/1/2017, Vol. 105 Issue 1, p3 

    An introduction is presented in which the author discusses another article in the issue that examines gut permeability in obese people with and without liver steatosis who underwent a weight-reduction program, and it mentions metabolic disorders and nonalcoholic fatty liver disease.

  • Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet. Machado, Mariana Verdelho; Cortez-Pinto, Helena // International Journal of Molecular Sciences;2016, Vol. 17 Issue 4, p481 

    Recently, the importance of the gut-liver-adipose tissue axis has become evident. Nonalcoholic fatty liver disease (NAFLD) is the hepatic disease of a systemic metabolic disorder that radiates from energy-surplus induced adiposopathy. The gut microbiota has tremendous influences in our...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics